← Back to Search

Housing and Mental Health Support for Exposure to Gun Violence (TRUE HAVEN Trial)

N/A
Recruiting
Led By Brita Roy, MD, MPH, MHS
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months
Awards & highlights

TRUE HAVEN Trial Summary

This trial aims to reduce gun violence by improving housing stability and mental health support in re-entry communities.

Who is the study for?
This trial is for residents in certain neighborhoods who have experienced gun violence. It's open to those re-entering society and their families, aiming to improve housing stability with financial aid and education. Mental health support is also provided through trained community counselors.Check my eligibility
What is being tested?
The 'TRUE HAVEN' intervention is being tested, which combines financial assistance for housing with educational support, as well as mental health services via a network of community members trained in trauma-informed counseling.See study design
What are the potential side effects?
Since this study focuses on social interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to the counseling sessions.

TRUE HAVEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in rates of gun violence
Secondary outcome measures
Change in financial security
Change in neighborhood social cohesion using the Social Cohesion sub-scale of the Sampson Collective Efficacy Scale
Change in participant self-efficacy based on the Generalized Self-Efficacy Scale
+1 more

TRUE HAVEN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The two components in the intervention arm of TRUE HAVEN are: housing support for recently incarcerated people as well as family members of currently incarcerated people, and mental wellness training for neighborhood residents to participate in trauma-informed care training sessions.
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,852 Previous Clinical Trials
2,676,671 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,154,589 Total Patients Enrolled
Brita Roy, MD, MPH, MHSPrincipal InvestigatorNew York University

Media Library

TRUE HAVEN Clinical Trial Eligibility Overview. Trial Name: NCT05723614 — N/A
Gunshot Wound Research Study Groups: Control, Intervention
Gunshot Wound Clinical Trial 2023: TRUE HAVEN Highlights & Side Effects. Trial Name: NCT05723614 — N/A
TRUE HAVEN 2023 Treatment Timeline for Medical Study. Trial Name: NCT05723614 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How extensive is the enrollment for this clinical examination?

"Affirmative, the data shared on clinicaltrials.gov depicts that this research is actively seeking volunteers. It was initially published on February 1st 2023 and its most recent update occured a month later, in March 27th 2023. The trial requires 61770 participants to be recruited from one single site."

Answered by AI

Is this experiment actively recruiting volunteers?

"Affirmative. Clinicaltrials.gov data affirms that this medical study, which was first listed on February 1st 2023, is currently recruiting participants. 61770 individuals must be enrolled from a single site for the trial to continue."

Answered by AI
~40222 spots leftby Sep 2026